![Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection | Science Immunology Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.abf3698/asset/b9862ff8-a179-4a51-8d48-75a8973a6f65/assets/graphic/abf3698-f3.jpeg)
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection | Science Immunology
![Clinical and immunological outcomes of SARS-CoV-2-infected vaccine responders, vaccine non-responders, and unvaccinated patients evaluated for neutralizing monoclonal antibody treatment at a single German tertiary care center: a retrospective cohort ... Clinical and immunological outcomes of SARS-CoV-2-infected vaccine responders, vaccine non-responders, and unvaccinated patients evaluated for neutralizing monoclonal antibody treatment at a single German tertiary care center: a retrospective cohort ...](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs15010-023-02171-z/MediaObjects/15010_2023_2171_Fig2_HTML.png)
Clinical and immunological outcomes of SARS-CoV-2-infected vaccine responders, vaccine non-responders, and unvaccinated patients evaluated for neutralizing monoclonal antibody treatment at a single German tertiary care center: a retrospective cohort ...
![Testing preexisting antibodies prior to AAV gene transfer therapy: rationale, lessons and future considerations - ScienceDirect Testing preexisting antibodies prior to AAV gene transfer therapy: rationale, lessons and future considerations - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2329050122000274-fx1.jpg)
Testing preexisting antibodies prior to AAV gene transfer therapy: rationale, lessons and future considerations - ScienceDirect
![Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans - Haveri - 2021 - European Journal of Immunology - Wiley Online Library Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans - Haveri - 2021 - European Journal of Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/04167a8d-b53a-4f8f-9eea-e568621e04d5/eji5182-fig-0005-m.jpg)
Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans - Haveri - 2021 - European Journal of Immunology - Wiley Online Library
![Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection | Science Immunology Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.abf3698/asset/921785e5-23f7-4ea3-a1d5-bf05e08785fe/assets/graphic/abf3698-f1.jpeg)
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection | Science Immunology
![JCI - SARS-CoV-2–specific memory B cells can persist in the elderly who have lost detectable neutralizing antibodies JCI - SARS-CoV-2–specific memory B cells can persist in the elderly who have lost detectable neutralizing antibodies](https://dm5migu4zj3pb.cloudfront.net/manuscripts/152000/152042/medium/JCI152042.f1.jpg)
JCI - SARS-CoV-2–specific memory B cells can persist in the elderly who have lost detectable neutralizing antibodies
![Vaccines | Free Full-Text | Rapid Quantification of SARS-CoV-2 Neutralising Antibodies Using Time-Resolved Fluorescence Immunoassay Vaccines | Free Full-Text | Rapid Quantification of SARS-CoV-2 Neutralising Antibodies Using Time-Resolved Fluorescence Immunoassay](https://www.mdpi.com/vaccines/vaccines-10-02149/article_deploy/html/images/vaccines-10-02149-g001-550.jpg)
Vaccines | Free Full-Text | Rapid Quantification of SARS-CoV-2 Neutralising Antibodies Using Time-Resolved Fluorescence Immunoassay
![JCM | Free Full-Text | Anti-Drug Antibodies in the Biological Therapy of Autoimmune Rheumatic Diseases JCM | Free Full-Text | Anti-Drug Antibodies in the Biological Therapy of Autoimmune Rheumatic Diseases](https://www.mdpi.com/jcm/jcm-12-03271/article_deploy/html/images/jcm-12-03271-g001.png)
JCM | Free Full-Text | Anti-Drug Antibodies in the Biological Therapy of Autoimmune Rheumatic Diseases
![Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection | Science Immunology Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.abf3698/asset/5537bc22-244d-4a85-91e3-8f44578aafcd/assets/graphic/abf3698-f2.jpeg)
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection | Science Immunology
![The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacs: Molecular Therapy Methods & Clinical Development The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacs: Molecular Therapy Methods & Clinical Development](https://www.cell.com/cms/attachment/b23ee2c2-9df6-494d-a2fd-f0c687ebafa4/fx1_lrg.jpg)